---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289468504.md"
description: "Purple Biotech shares are trading higher after the company announced the presentation of new preclinical data from its lead CAPTN-3 program, IM1240, at EACR 2026 Annual Congress."
datetime: "2026-06-11T11:17:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289468504.md)
  - [en](https://longbridge.com/en/news/289468504.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289468504.md)
generator: "portal-rs"
---

# 

Purple Biotech shares are trading higher after the company announced the presentation of new preclinical data from its lead CAPTN-3 program, IM1240, at EACR 2026 Annual Congress.

### Related Stocks

- [PPBT.US](https://longbridge.com/en/quote/PPBT.US.md)

## Related News & Research

- [Purple Biotech presents new preclinical IM1240 cancer data at EACR 2026 congress](https://longbridge.com/en/news/295224384.md)
- [FULC: Merger forms a well-funded migraine biotech with clinical milestones expected through 2029](https://longbridge.com/en/news/296111857.md)
- [Legend Biotech Sets September 24, 2026 AGM With Expanded Equity Plan on Agenda](https://longbridge.com/en/news/296267145.md)
- [Corning sets Q3 2026 dividend at R$ 0.25 per unit](https://longbridge.com/en/news/296635714.md)
- [Public Storage announces R$ 0.41 per unit dividend for Q3 2026](https://longbridge.com/en/news/296635332.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**